Adjuvant therapy for high-risk cutaneous squamous cell carcinoma: 10-year review.

Newman, Jason G; Hall, Mary A; Kurley, Sarah J; Cook, Robert W; Farberg, Aaron S; Geiger, Jessica L; Koyfman, Shlomo A

Newman, Jason G; Hall, Mary A; Kurley, Sarah J; Cook, Robert W; Farberg, Aaron S; Geiger, Jessica L; Koyfman, Shlomo A.

Afiliação

Newman JG; Department of Otorhinolaryngology - Head and Neck Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Hall MA; Research and Development, Castle Biosciences, Inc., Friendswood, Texas, USA.
Kurley SJ; Research and Development, Castle Biosciences, Inc., Friendswood, Texas, USA.
Cook RW; Research and Development, Castle Biosciences, Inc., Friendswood, Texas, USA.
Farberg AS; Section of Dermatology, Baylor University Medical Center, Dallas, Texas, USA.
Geiger JL; Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, Ohio, USA.
Koyfman SA; Department of Radiation Oncology, Cleveland Clinic, Cleveland, Ohio, USA.

Head Neck ; 43(9): 2822-2843, 2021 09.

Article em En | MEDLINE | ID: mdl-34096664

Assuntos

Carcinoma de Células Escamosas; Neoplasias Cutâneas; Carcinoma de Células Escamosas/terapia; Terapia Combinada; Humanos; Margens de Excisão; Estudos Retrospectivos; Neoplasias Cutâneas/terapia

Palavras-chave

adjuvant chemotherapy; adjuvant radiation therapy; cutaneous squamous cell carcinoma; immunotherapy; targeted therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Carcinoma de Células Escamosas Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google